U.S. Markets open in 3 hrs 30 mins

Biktarvy: Drug Insights and Sales Forecasting, 2019-2021 - ResearchAndMarkets.com

The "Biktarvy - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Biktarvy - Drug Insight, 2019 report provides comprehensive information of the drug, Biktarvy. It includes drugs overview, Biktarvy mechanism of action, clinical trials, regulatory milestones, deals & Biktarvy's partnerships. It further provides Biktarvy`s patents (US & EU) and its API manufacturers details in the United States, Europe, China and India.

It also features the historical and forecasted Biktarvy sales till 2021. The report also throws light on Biktarvy market competition and emerging therapies in the same space as Biktarvy. Biktarvy SWOT analysis is also featured.

Scope of the Report

  • A comprehensive Biktarvy overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Biktarvy Patent information in United States (US) and Europe (EU) has been highlighted
  • Biktarvy API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Biktarvy sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Biktarvy operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Biktarvy SWOT analysis

Reasons to Buy

  • Establish a comprehensive understanding of the drug, Biktarvy
  • Access to Biktarvy API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Biktarvy patents for the major markets- US and EU
  • Understand current and future Biktarvy`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Biktarvy
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Biktarvy
  • Identify opportunities in the same area as with Biktarvy SWOT analysis

Key Topics Covered

1. Report Introduction

2. Biktarvy - Overview

  • Biktarvy Product Description
  • Biktarvy Route of Synthesis
  • Biktarvy Mechanism of Action
  • Biktarvy Pharmacology
  • Biktarvy Pharmacodynamics
  • Biktarvy Pharmacokinetics
  • Biktarvy Adverse Reactions
  • Biktarvy Clinical Trials
  • Biktarvy Regulatory Milestones
  • Biktarvy Development Activities

3. Global API Manufacturers

  • United States
  • Europe
  • China
  • India

4. Product Details

  • United States
  • Europe

5. Biktarvy Global Sales Assessment

  • Biktarvy Sales Global(Historical)
  • Biktarvy Sales Global(Forecasted)

6. Biktarvy Patent Details

7. Biktarvy Market Competition

8. Biktarvy Emerging Therapies

8.1. Drug name: Company name

  • Product Description
  • Research & Development
  • Product Development Activities

9. Biktarvy SWOT Analysis

List of Tables

Table 1: Biktarvy, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Biktarvy Product Details, United States

Table 8: Biktarvy Product Details, Europe

Table 9: Biktarvy, Historical Global Sales till 2017 (in million USD)

Table 10: Biktarvy, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Biktarvy

Table 12: Biktarvy Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Biktarvy

Figure 2: Biktarvy, Historical Global Sales till 2017 (in million USD)

Figure 3: Biktarvy, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Biktarvy

Figure 5: API Manufacturers Region wise

For more information about this report visit https://www.researchandmarkets.com/r/s21f8b

View source version on businesswire.com: https://www.businesswire.com/news/home/20191227005260/en/


Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900